Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

327

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

327 results for “Tg”

Learn how ShareScore rates datasets ↗
zenodo48/100

TG-CSR Annotations

<p>Individual raw and normalized label data for the TG-CSR (Theoretically-Grounded Commonsense Reasoning) benchmark.</p>

opencc-by-4.0May 2023View details →
zenodo40/100

Dataset: TG Therapeutics, Inc. (TGTX) Stock Performance

This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.

opencc-zeroJun 2024View details →
zenodo40/100

3dpf zebrafish larvae, 96 well plate,Tg(wt1b:EGFP), dorsal view, ACQUIFER Imaging Machine

<p>Datasets originate from internal test runs at ACQUIFER on the Imaging Machine (see also application note on &quot;<a href="https://www.acquifer.de/downloads/Clicktoolappnote_ImagingMachine.pdf">The ACQUIFER PlateViewer: A tool for visualizing high content screening data and supervised feedback microscopy</a>&quot;)</p> <p>The datasets contain images acquired from 96 <em>Tg(wt1b:EGFP)</em> embryos at 3 dpf aligned in agarose cavities generated with 3d printed orientation&nbsp;tools (<a href="https://rdcu.be/byto9">Wittbrodt, Jonas N., Urban Liebel, and Jochen Gehrig. &quot;Generation of orientation tools for automated zebrafish screening assays using desktop 3D printing.&quot;&nbsp;<em>BMC biotechnology</em>&nbsp;14.1 (2014): 36.</a>):</p> <p>- 2x, 4x, 10x views</p> <p>- for each well (e.g. <em>A001</em>) a multi-color z-stack was acquired, with &nbsp;N z-slices (SL<em>NNN</em>) in two channels: BF (CO<em>6</em>) and GFP (CO<em>3</em>)</p> <p>Example file name containing metadata:&nbsp;-<strong><em>A001-</em></strong>-PO01--LO001--<em><strong>CO3</strong></em>--<em><strong>SL001</strong></em>--PX32500--PW0100--IN0100--TM281--X014580--Y011262--Z210710--T0200256066--WE00001.tif</p> <p>Used also as benchmark dataset for Multi-Template Matching by Thomas, LSV&nbsp;and Gehrig, J</p> <p>See implementation in Fiji&nbsp;<a href="https://github.com/LauLauThom/MultipleTemplateMatching">https://github.com/LauLauThom/MultipleTemplateMatching</a></p> <p>and in KNIME&nbsp;<a href="https://github.com/LauLauThom/MultipleTemplateMatching-KNIME">https://github.com/LauLauThom/MultipleTemplateMatching-KNIME</a></p> <p>Contact:</p> <p>j.gehrig(at)acquifer.de, l.thomas(at)acquifer.de</p> <p>&nbsp;</p> <p><strong>Ethic statement</strong></p> <p>The work presented does not involve work with animals according to German and European<br> legislation. All experiments have been performed at stages prior to the legal onset of animal life.<br> To obtain zebrafish embryos and larvae, fish were maintained in closed stocks at Heidelberg University.<br> Zebrafish husbandry and experiments are under the institutional control of the Universities animal<br> welfare agency. All the zebrafish husbandry and experimental procedures were performed in<br> accordance with the German animal welfare standards (Tierschutzgesetz &sect;11, Abs. 1, Nr. 1, husbandry<br> permit number 35-9185.64/BH Wittbrodt) and in accordance with German and European Union animal<br> welfare guidelines. The fish facility is under the supervision of the local representative of the animal<br> welfare agency.</p>

opencc-by-4.0Apr 2019View details →
zenodo40/100

Figure. PCA analysis based on GH-MspI, GH-AluI, PRL, and DGAT1 loci in Turkish native cattle breeds (Turkish Grey - TG, East Anatolian Red - EAR, Anatolian Black - AB, and South Anatolian Red - SAR). in Growth hormone (GH), prolactin (PRL), and diacylglycerol acyltransferase (DGAT1) gene polymorphisms in Turkish native cattle breeds

Figure. PCA analysis based on GH-MspI, GH-AluI, PRL, and DGAT1 loci in Turkish native cattle breeds (Turkish Grey - TG, East Anatolian Red - EAR, Anatolian Black - AB, and South Anatolian Red - SAR).

opencc-by-4.0Dec 2014View details →
zenodo36/100

TG 118: Building Upon ICRP92 on RBE, Radiation Weighting Factor and Q Factor

<p>TG 118 started as a WP of C1.&nbsp; During the past year, the WP met several times to review the literature and prepare the ToR which were accepted by the MC.&nbsp; From this TG 118 was appointed, and the kick-off zoom meeting was held on Sept 22, 2021 with most of the above members in attendance.&nbsp; The goal of TG118 is to examine questions of RBE, radiation weighting factor, and Q.&nbsp; At the first meeting, the group assessed membership for whether it is adequate to do the work outlined for the team and also set some plans for future meetings.&nbsp; A series of workshops examining specific questions will be set-up in the coming months.&nbsp; Among the areas considered important were the influence of dose-rate (including high dose-rate FLASH, even p+ FLASH) on RBE, examination of differences in and out of the Bragg peak, secondary cancer studies, and others.&nbsp; The group also decided that a review of ICRP 92 would be of value.&nbsp; In particular, examining the report&rsquo;s comments about future studies, difficulties encountered in RBE work, and approaches for determination of RBE and RBEM will be important in shaping the coming report.&nbsp; This will also be done at an upcoming meeting.</p>

opencc-by-2.0Nov 2021View details →
zenodo36/100

TG 91: Radiation Risk Inference at Low-Dose and Low-Dose Rate Exposure for Radiological Protection Purposes

<p>The detriment-adjusted nominal risk coefficients recommended by ICRP have been based, to a large extent, on data obtained from the atomic bomb survivors in Japan. ICRP introduced a Dose and Dose-Rate Effectiveness Factor (DDREF) of 2 to include in calculations of these risk coefficients for application at the low doses and low-dose rate exposures typical in radiological protection. The DDREF was included to account for the survivors&rsquo; single acute exposure, and because a linear quadratic instead of a linear risk to dose response was thought to be the most plausible biological model.</p> <p>This paper summarizes the recent work of ICRP Task Group 91 on this topic. Task Group activities have included reviews of the history of low-dose and low-dose-rate effects, various exposure scenarios and their doses and dose rates, radiation-induced effects at the molecular, cellular, animal, and human level, and biologically-based mechanistic models of carcinogenesis. The Task Group performed a meta-analysis of low-dose-rate epidemiological studies, and re-analyses of published results on radiation-induced effects among animal models and among Japanese atomic bomb survivors.</p>

opencc-by-2.0Nov 2021View details →
zenodo36/100

TG 115: Risk and Dose Assessment for Radiological Protection of Astronauts

<p>During the past six decades, many human spaceflights have been launched. Among the factors that affect health and performance of astronauts during and after their space missions, space radiation presents unique challenges. ICRP Publication 123 (2013) addressed the challenges in the assessment of space radiation exposure to astronauts, covering radiation environments in space, quantities used in radiological protection, methods of measurement, radiation fields inside spacecraft and on planetary surfaces, radiation fields and doses in the human body, and a short section on operational radiological protection.</p> <p>Currently, space agencies involved in human spaceflight use a variety of methods and quantities to assess dose and risks to their astronauts, as well as a variety of restrictions in the management of human spaceflights. In 2018, agencies involved in the International Space Station (ISS) proposed collaboration with ICRP to examine effects that may impact crew health and mission success, and to develop a common health risk assessment framework and recommendations on exposure limits for exploration-class human spaceflight missions. In response, ICRP established TG115 Risk and Dose Assessment for Radiological Protection of Astronauts to develop a comprehensive framework for risk and dose assessment for radiological protection of astronauts, including a set of basic objectives, a review of the current understanding of effects and risks from space radiation, a broadly-applicable risk and dose assessment methodology, and an assessment of the use of risk as a radiological protection quantity. Health endpoints considered by TG115 include cancer, however, the intent is to broaden the scope to include additional endpoints including potential tissue effects.</p> <p>This paper provides an update on current activities of TG115. It is envisaged that, on the long-term, TG115 will address how the principles of radiological protection are applied to space environment. The effort may lead to recommendations on setting and using numerical values of limits, constraints, and reference levels. This would mirror ICRP Publication 132 (2016), where radiological protection from cosmic radiation in aviation is addressed.</p>

opencc-by-2.0Nov 2021View details →
zenodo36/100

TG 111: Factors Governing the Individual Response of Humans to Ionising Radiation

<p>The current system of radiological protection, that aims to avoid tissue reactions (deterministic effects) and minimize risk of stochastic effects (cancers and hereditary effects), through justification and optimisation of practices and limitation of exposures, is based on estimations of risk to a notional average person. The use of an age- and sex-averaged approach is not a reflection of the reality of population structures, but is a pragmatic approach. However, we know that there are variations in radiosensitivity between individuals within the population. The underlying reasons for this variation can be genetic (for example, the radiation-sensitive syndromes such as ataxia telangiectasia and Gorlin syndrome), epigenetic and also environmental or behavioural (for example, the difference in lung cancer risks in smokers and non-smokers). A better understanding of the factors that underlie inter-individual variation in response to radiation, and the magnitude of the variation could impact on the approaches adopted to radiation protection in the occupational, medical and public sectors. One example where this may impact is in radiotherapy for cancer, where severe normal tissue complications can be observed in a sub-set of the individuals treated. Understanding the subpopulations for which such severe complications occur, and the underlying mechanistic basis could inform radiotherapy treatment decision making, improving tumour cure rates while avoiding the severe complications. In 2018, the International Commission on Radiological Protection established a Task Group, TG111 to consider Factors Governing the Individual Response of Humans to Ionising Radiation. The aim of this presentation is to review the current state of knowledge on variation in individual response to radiation and to provide an update on progress with the work of the ICRP Task Group.</p>

opencc-by-2.0Nov 2021View details →
zenodo36/100

TG 36: The Revision of Dose Coefficients in Diagnostic Nuclear Medicine

<p>The ICRP Task Group 36 &quot;Radiation Dose to Patients in Diagnostic Nuclear Medicine&quot; is currently working on the revision of ICRP Publication 128 (2015) by updating the dose coefficients using the new ICRP adult and paediatric reference voxel phantoms from ICRP Publications 110 (2009) and 143 (2020), nuclear decay data from Publication 107 (2008) and the dosimetry methodology of ICRP described in Publication 103 (2007). Also the biokinetic information on the radiopharmaceuticals is being updated based on the most recent literature data and will be presented in form of compartmental structures, similarly to what already done by ICRP for workers and members of the public. To assess more realistically the dose to the urinary bladder wall, which is in most cases one of the most exposed tissues, a dynamic bladder model will also be introduced.</p> <p>Although the quantity effective dose, calculated for a (hypothetical) reference person, is useful (and used) in comparing exposures, and consequently risks, from different radiopharmaceuticals and/or different alternative diagnostic procedures, its application in medicine is controversial and also goes beyond its originally intended purpose. For the specific work of Task Group 36 in diagnostic nuclear medicine it is indeed planned to provide estimates of whole body dose quantities that account for the fact that some investigations are performed on patients of only one sex (e.g., differential diagnosis of prostate cancer with&nbsp;<sup>18</sup>F-choline) or in patient groups with anatomical or physiological characteristics differing from the reference persons (for instance, patients with abnormal liver or spleen masses due to diffuse parenchymal disease, or with unilateral kidney blockage).</p> <p>It is therefore appreciated that the ICRP, in its mission to keep the recommendations fit for purpose, is seeking to revise the concept of the radiation detriment to account for age- and sex-dependence of radiation sensitivity, and to recommend tissue weighting factors which are differentiated accordingly. The idea of no longer referring the effective dose for a hypothetical reference person only, but separately for different subgroups in the population (depending on age, sex, health condition or other characteristics) would actually be very practicable in all medical dosimetric application, including nuclear medicine.</p> <p>Presented by Augusto Giussani on behalf of the whole Task Group.</p>

opencc-by-2.0Nov 2021View details →
zenodo36/100

TG 114: Reasonableness and Tolerability in the System Of Radiological Protection: ICRP TG114 On-Going Reflections

<p>The model of reasonableness and tolerability of radiological risk is a conceptual framework for the implementation of the ICRP principles of optimisation of protection (guided by constraints and reference levels) and application of dose limits, based mainly on the level of exposure, and closely related to the level of risk. Discussions about reasonableness and tolerability have been part of ICRP publications for many years, including the introduction of a model of risk tolerability in Publication 60. More recently, Publication 101 developed the approach to address the implementation of the optimisation process including the involvement of stakeholders and the way to elucidate what is reasonably achievable. Further considerations have been addressed while examining the ethic, identifying four core values underpinning the system of radiological protection (Publication 138). In 2019, ICRP has set up a dedicated task group (TG114) to review the historical and current perspectives on reasonableness and tolerability in order to consolidate and clarify Publication 103, and to prepare the considerations and basis needed for development of future recommendations.</p> <p>The ICRP on-going reflections on reasonableness and tolerability in the system of radiological protection have started to addressed a series of questions including, for example: What is the link between tolerable and reasonable? What are the considerations and criteria on which the concepts of tolerability and reasonableness are based? What are some strategies to assist in balancing competing values in determining what is tolerable and/or reasonable?</p> <p>For addressing these questions, the model of reasonableness and tolerability of radiological risk is revisited with the following objectives:</p> <ul> <li>Investigate the rational for the application of the tolerability of risk as well as the borders with unacceptable level of risks and compare with the approaches adopted for managing other risks.</li> <li>Better articulate the link between tolerability and reasonableness in the process of implementation the radiological protection system, with clarification on the criteria to be considered for defining &ldquo;where we don&rsquo;t want to go above&rdquo; and which process could be put in place for evaluating &ldquo;what is reasonable&rdquo;.</li> <li>Refine the radiological criteria to be considered and their link with dose limits and reference levels, relying on the radiological detriment as benchmark for tolerability and reasonableness as well as using risk comparison but without limiting to numerical criteria.</li> <li>Emphasize the importance of the application of the model for the different exposure situations, including the deliberative process with the stakeholders for the implementation of the optimisation principle, referring to good judgement, fairness, practicability, and moderateness.</li> </ul> <p>Presented by Thierry Schneider on behalf of the whole Task Group.</p>

opencc-by-2.0Nov 2021View details →
zenodo36/100

Data of thermal analysis (TG) of Hilber et al. 2024

Open the record for dataset details and reuse information.

opencc-by-4.0Jun 2024View details →
zenodo36/100

Hackathon - TF-TG literature triage Gold Standard corpus

<p>This link contains the gold standard corpus for training the systems aiming at classifying or triaging the documents (PubMed abstracts) in relevant or not relevant for TF-TG relations. Note that this is not purely a curation triage, but we are primarily looking whether the abstracts do describe/characterize TF-TG interactions (positive training set labeled as &ldquo;1&rdquo; or they don&#39;t (negative training set labeled as &ldquo;0&rdquo;). &nbsp;</p> <p>This dataset was manually classified by domain experts into these to classes.</p> <p>Note that in PubMed there is a very considerable class imbalance, implying that there is only a very small fraction of TF-TG relations relevant literature subset. The resulting classifier should be useful to triage the entire PubMed database.</p> <ul> <li> <p>Name: <a href="https://zenodo.org/record/2562939/files/greekc_triage_training_v02.tsv?download=1">greekc_triage_training_v02.tsv</a></p> </li> <li> <p>Example:</p> </li> </ul> <p>11731616 &nbsp;&nbsp;&nbsp;[{&quot;sourceid&quot;:&quot;11731616&quot;,&quot;sourcedb&quot;:&quot;PubMed&quot;,&quot;text&quot;:&quot;Homeobox protein Gsh-1-dependent regulation of the rat GHRH gene promoter. Although GHRH is known to play a pivotal role in the regulation of the GHRH-GH-IGF-I axis, the molecular mechanism of GHRH gene expression has not yet been examined. Here we studied the transcriptional regulation of the GHRH gene 5&#39;promoter using an in vitro experimental model system. We especially focused on the role of homeobox transcriptional factor Gsh-1, because a dwarf phenotype and abolished GHRH expression was observed in Gsh-1 knockout mice. First, we cloned human Gsh-1, which showed 87.3% homology with mouse Gsh-1 at the nucleotide level. When the 5&#39;-promoter region of the rat GHRH gene was introduced into the human placental cell line JEG-3, in which we found the endogenous expression of Gsh-1 as well as GHRH mRNA, substantial transcriptional activity of the promoter was recognized. Promoter activity was further enhanced by overexpression of Gsh-1 protein, whereas it was substantially reduced by elimination of Gsh-1 binding sites. EMSA confirmed the actual binding of Gsh-1 on the multiple binding sites of GHRH gene promoter. Finally, coexpression of CREB-binding protein significantly enhanced the Gsh-1-induced GHRH gene expression, suggesting the cooperative role of the coactivator protein. Because Gsh-1 is found to be expressed in the hypothalamus of the adult rat, our data provide evidence that the Gsh-1 homeobox protein plays a key role in the expression of the GHRH gene.&quot;,&quot;denotations&quot;:[{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:84,&quot;end&quot;:88}},{&quot;obj&quot;:&quot;Gene:288457&quot;,&quot;span&quot;:{&quot;begin&quot;:17,&quot;end&quot;:22}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:55,&quot;end&quot;:59}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:146,&quot;end&quot;:150}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:193,&quot;end&quot;:197}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:295,&quot;end&quot;:299}},{&quot;obj&quot;:&quot;Gene:14842&quot;,&quot;span&quot;:{&quot;begin&quot;:430,&quot;end&quot;:435}},{&quot;obj&quot;:&quot;Gene:14601&quot;,&quot;span&quot;:{&quot;begin&quot;:477,&quot;end&quot;:481}},{&quot;obj&quot;:&quot;Gene:14842&quot;,&quot;span&quot;:{&quot;begin&quot;:509,&quot;end&quot;:514}},{&quot;obj&quot;:&quot;Gene:219409&quot;,&quot;span&quot;:{&quot;begin&quot;:553,&quot;end&quot;:558}},{&quot;obj&quot;:&quot;Gene:14842&quot;,&quot;span&quot;:{&quot;begin&quot;:599,&quot;end&quot;:604}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:669,&quot;end&quot;:673}},{&quot;obj&quot;:&quot;Gene:219409&quot;,&quot;span&quot;:{&quot;begin&quot;:783,&quot;end&quot;:788}},{&quot;obj&quot;:&quot;Gene:2691&quot;,&quot;span&quot;:{&quot;begin&quot;:800,&quot;end&quot;:804}},{&quot;obj&quot;:&quot;Gene:288457&quot;,&quot;span&quot;:{&quot;begin&quot;:940,&quot;end&quot;:945}},{&quot;obj&quot;:&quot;Gene:288457&quot;,&quot;span&quot;:{&quot;begin&quot;:1010,&quot;end&quot;:1015}},{&quot;obj&quot;:&quot;Gene:288457&quot;,&quot;span&quot;:{&quot;begin&quot;:1068,&quot;end&quot;:1073}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:1107,&quot;end&quot;:1111}},{&quot;obj&quot;:&quot;Gene:54244&quot;,&quot;span&quot;:{&quot;begin&quot;:1152,&quot;end&quot;:1172}},{&quot;obj&quot;:&quot;Gene:288457&quot;,&quot;span&quot;:{&quot;begin&quot;:1200,&quot;end&quot;:1205}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:1214,&quot;end&quot;:1218}},{&quot;obj&quot;:&quot;Gene:288457&quot;,&quot;span&quot;:{&quot;begin&quot;:1304,&quot;end&quot;:1309}},{&quot;obj&quot;:&quot;Gene:288457&quot;,&quot;span&quot;:{&quot;begin&quot;:1408,&quot;end&quot;:1413}},{&quot;obj&quot;:&quot;Gene:29446&quot;,&quot;span&quot;:{&quot;begin&quot;:1473,&quot;end&quot;:1477}}]}] &nbsp;&nbsp;&nbsp;1</p> <ul> <li> <p>Format: tsv-separated columns (PMID, PubAnnotation JSON formated results of Pubtator for this record together with the automatically detected gene mentions using GnormPlus providing the Entrez Gene Identifiers together with the mention offsets, i.e. start and end character positions, corresponding class label of the records (1= relevant, 0=nonrelevant))</p> </li> <li> <p>PubAnnotation format description: <a href="http://www.pubannotation.org/docs/annotation-format/">http://www.pubannotation.org/docs/annotation-format/</a></p> </li> <li> <p>PubTator record retrieval description:</p> </li> </ul> <p>https://www.ncbi.nlm.nih.gov/CBBresearch/Lu/Demo/tmTools/curl.html</p> <p><strong>Remember:</strong> One must notice that this dataset is high imbalanced, with very few cases of the positive class. The additional files could also be explored to build the model or even to build a classifier working at the level of sentences instead of abstracts,</p> <p>&nbsp;</p>

opencc-by-4.0Feb 2019View details →
zenodo36/100

Hackathon - TF-TG literature triage unlabelled data

<p>Once literature triage system is ready it is time to actually try to apply if to records that do not have any label in order to find the subset that does describe TF-TG interactions (are relevant). This is the corpus that has to be labeled by the systems created (hopefully) during the hackathon. To make the results more useful we have pre-selected records that do mention TFs by exploiting either automatic human TF mention recognition or external references from databases that have manually curated information on transcription factors (from GeneRif or UniProt). This means that these abstracts should be enriched with TF relevant records. This record has the same format as the training data except that the last column with the class label is missing.</p> <p>It contains PMIDs and Abstracts.</p> <ul> <li> <p>Name: <a href="https://zenodo.org/record/2562913/files/greekc_triage_unlabelled_v01.tsv?download=1">greekc_triage_unlabelled_v01.tsv</a></p> </li> <li> <p>Example:</p> </li> <li> <p>Format: tsv-separated columns (PMID, PubAnnotation JSON formated results of Pubtator for this record together with the automatically detected gene mentions using GnormPlus providing the Entrez Gene Identifiers together with the mention offsets, i.e. start and end character positions</p> </li> <li> <p>PubAnnotation format description: <a href="http://www.pubannotation.org/docs/annotation-format/">http://www.pubannotation.org/docs/annotation-format/</a></p> </li> <li> <p>PubTator record retrieval description:</p> </li> </ul> <p>https://www.ncbi.nlm.nih.gov/CBBresearch/Lu/Demo/tmTools/curl.html</p> <p><strong>Warning:</strong> This file is quite big!</p>

opencc-by-4.0Feb 2019View details →
zenodo36/100

Jamboree - TF-TG literature triage dataset

<p>This file contains the entire set of PMIDs (589,448) that will be used for the manual literature exercise doen using the PubTator interface. &nbsp;The actual instruction of the triage jamboree track are available at:</p> <p><a href="http://greekc.org/wp-content/uploads/2019/02/Abstract_classification_guidelines_TRE_malaga.doc">http://greekc.org/wp-content/uploads/2019/02/Abstract_classification_guidelines_TRE_malaga.doc</a></p> <ul> <li> <p>Name: <a href="https://zenodo.org/record/2562881/files/jamboree_triage_all_PMID_v01.txt?download=1">jamboree_triage_all_PMID_v01.txt</a></p> </li> <li> <p>Example: 17869381</p> </li> <li> <p>Format: one PMID in each line</p> </li> </ul> <p>Smaller subsets will be distributed to each participant in the triage jamboree to carry out a manual triage/classification exercise.</p>

opencc-by-4.0Feb 2019View details →
zenodo36/100

Annotated necrosis and mitotic figures on 230 rat liver slides of the Open TG-GATEs dataset

<pre># Annotated necrosis and mitotic figures on 230 rat liver slides of the Open TG-GATEs dataset This dataset contains polygonal annotations of 230 whole slide images of the Open TG-GATEs dataset. The annotations were created by Bayer pathologists in a project collaboration between Bayer Pharmaceuticals and Aignostics GmbH. ## Dataset Files This dataset contains only text files which are referring to whole slide images of the Open TG-GATEs dataset. The images are not distributed with this dataset. Image URLs and their respective `md5` checksums are stored in `slides.json`. The annotations are available in the raw json format used in the collaboration as well as in converted [`geojson`](https://geojson.org/) format for easy import into other tools. | file | description | |:-----------------------------------|:-------------------------------------| | slides.json | URLs/md5-checksums of each slide | | annotations/raw/\*.svs.json | original format tissue annotations | | annotations/geojson/\*.svs.geojson | tissue annotations in geojson format | ## Annotated Lesions / Classes The dataset was annotated by 6 expert pathologists with the goal of labelling &quot;Necrosis&quot; and &quot;Mitotic Figures&quot; on rat liver whole slide images. Additional areas in the slides were labelled to improve model training. An overview of the annotated classes is given in the table below: | label | count | area (px^2) | |:---------------------------------------------------|------:|-------------:| | Necrosis (area) | 1576 | 386769004.0 | | Necrosis (single cell) | 1497 | 1624837.5 | | Mitosis | 5205 | 9322482.0 | | Single cell necrosis/apoptosis | 1531 | 1446001.0 | | Central vein | 1125 | 27947588.0 | | Connective tissue | 63 | 8478992.5 | | Dark hepatocytes | 763 | 2516812.5 | | Extramedullary hematopoiesis | 73 | 189508.0 | | Hemorrhage | 142 | 2231979.0 | | Inflammatory infiltrate | 1382 | 9859337.5 | | Large vessels | 224 | 597148962.0 | | Neoplasia | 176 | 478842.5 | | Oval cell/bile duct proliferation | 47 | 1621104.5 | | Parenchyma | 3249 | 673395978.0 | | Portal tract | 1067 | 40819943.0 | | Other lesions | 5 | 9251.0 | | Staining, contamination, and out-of-focus artifact | 46 | 4484697.0 | The pathologists labeled the following number of lesions: | pathologist | annotations | |:--------------|------------:| | pathologist-0 | 15660 | | pathologist-1 | 1749 | | pathologist-2 | 660 | | pathologist-3 | 79 | | pathologist-4 | 22 | | pathologist-5 | 1 | ## Reference The 230 slides of the Open TG-GATEs Pathological Image Database which the annotations refer to are part of the `Toxicogenomics Project and Toxicogenomics Informatics Project under CC Attribution-Share Alike 2.1 Japan` (`CC-BY-SA-2.1-JP`) and are available for download via [10.18908/lsdba.nbdc00954-02-000](http://doi.org/10.18908/lsdba.nbdc00954-02-000). ## License All `*.json` and `*.geojson` files in this distribution are licensed under the same `CC Attribution-Share Alike 2.1 Japan` (`CC-BY-SA-2.1-JP`) license as the Open TG-GATEs Pathological Image Database. The license text is included in the file `LICENSE` in the distribution archive. ## Acknowledgements We thank Dr. Maximilian Alber[^5], Oliv&eacute;r Atanaszov[^5] and Dr. Sharon Ruane[^5] for providing support, the annotation platform, the model training infrastructure and for the great collaboration. We also thank Dr. Yoshinobu Igarashi[^6] for providing insight and advice regarding the dataset and its licensing. [^5]: Aignostics GmbH [^6]: National Institutes of Biomedical Innovation, Health and Nutrition - Toxicogenomics Informatics Project </pre>

openJan 2023View details →
zenodo36/100

TG 100 focused peer reviewed article summary - June2022

<p>A collection of peer reviewed papers that use TG-100 tools. This reference matrix gives a quick way to browse relevant publications</p>

opencc-by-4.0May 2022View details →
zenodo36/100

TG-CSR: Theoretically-Grounded Commonsense Reasoning Benchmark

<p>Achieving machine common sense has been a longstanding problem within Artificial Intelligence. Thus far, benchmark data sets that are grounded in a theory of common sense and can be used to conduct rigorous, semantic evaluations of common sense reasoning (CSR) systems have been lacking. One expectation of the AI community is that neuro-symbolic reasoners can help bridge this gap towards more dependable systems with common sense. We propose a novel benchmark, called <em>Theoretically Grounded common sense Reasoning (TG-CSR)</em>, modeled as a set of question-answering instances, with each instance grounded in a semantic category of common sense, such as space, time, and emotions. The benchmark is few-shot i.e., only a few training and validation examples are provided in the public release to avoid the possibility of overfitting. Results from recent evaluations suggest that TG-CSR is challenging even for state-of-the-art statistical models. Due to its semantic rigor, this benchmark can be used to evaluate the common sense reasoning capabilities of neuro-symbolic systems.</p>

opencc-by-4.0Jan 2023View details →
zenodo36/100

AAPM TG 236 Report 236: Recommendations on volume-image-based treatment planning, dosimetry, and quality management for HDR intracavitary brachytherapy: Part I breast

<p>This is a zipped file&nbsp;for Appendix A.1 DVH validation using reference DCIOM datasets&nbsp;for AAPM TG report 236: Part I. Intracavitary breast brachytherapy. One can download and unzip the file. These are CT images and a structure file in DICOM format&nbsp;to validate the DVH information in your&nbsp;HDR brachytherapy treatment planning system either Varian BrachyVision or Elekta Oncentra. One can import all the DICOM files into your brachytherapy TPS and compute the dose. One can follow the instruction described in detail in Appendix A.1 of the AAPM TG 236: Part I report.</p>

opencc-by-4.0Sep 2023View details →
ClinicalTrials.gov36/100

Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee

ClinicalTrials.gov study NCT01221441. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

ClinicalTrials.gov study NCT01047501. IPD Sharing: NO. Countries: 1. Publications: 13.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.